The JPM Healthcare Conference is the world’s premier healthcare investment symposium, bringing together senior leaders across biotech, pharmaceuticals, medtech, digital health, and finance. The 45th annual edition (January 11–14, 2027) is an invitation‑only event where capital allocators, corporate executives, and innovators converge to set priorities and drive strategic decisions for the year ahead.

Key Highlights

• Attendance: Approximately 8,000 global healthcare professionals including investors, corporate executives, analysts, and policymakers.
  • Presentations: Around 500+ company presentations and corporate briefings during JPM Week.
  • Innovation & Insights: Focused coverage of breakthrough therapies, AI and data‑driven drug discovery, digital health, and evolving care delivery models.
  • Deal‑Making & Partnerships: A primary forum for M&A, licensing, strategic partnerships, and capital deployment across the healthcare sector.
  • Networking: C‑suite presentations, analyst panels, and private meetings provide high‑value face‑to‑face time with decision makers.

Why San Francisco Matters

San Francisco and the broader Bay Area are among the world’s largest life‑sciences hubs. The region hosts a dense cluster of biotech and life‑science companies, leading research institutions, and strong venture capital activity—making it a natural backdrop for an investment‑driven event of this scale.

Venue & Access

The conference is centered on the historic Westin St. Francis Hotel in Union Square, San Francisco. The hotel and the surrounding Union Square neighborhood act as the central hub for company presentations, informal meetings, and many JPM  Week activities. Participation in the JPM Healthcare Conference is by invitation; many sessions and investor briefings are private.